The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Cancer epigenetics
Abstract
The field of cancer epigenetics is evolving rapidly on several fronts. Advances in our understanding of chromatin structure, histone modification, transcriptional activity and DNA methylation have resulted in an increasingly integrated view of epigenetics. In response to these insights, epigenetic therapy is expanding to include combinations of histone deacetylase inhibitors and DNA methyltransferase inhibitors. Zebularine, an orally administerable DNA methyltransferase inhibitor, has been a very promising recent addition to our arsenal of potentially useful drugs for epigenetic therapy. Aberrant DNA methylation patterns provide three powerful diagnostic applications as classification markers, sensitive detection markers, and risk assessment markers. Classification studies continue to increase in marker complexity, now incorporating microarrays, high-throughput bisulfite genomic sequencing and mass spectrometry, as the field moves to human epigenome projects. Sensitive detection technology has expanded from primarily blood-based cancer detection to include applications on a wide diversity of sample sources and is now also making inroads as a molecular risk assessment tool.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Induction of DNA methylation and gene silencing by short interfering RNAs in human cells
Kawasaki, H., & Taira, K. (2004) · Nature · doi:10.1038/nature02889 · Cited by 367
RetractedRoman-Gomez, J., Jimenez-Velasco, A., Castillejo, J. A., Agirre, X., Barrios, M., Navarro, G., Molina, F. J., Calasanz, M. J., Prosper, F., Heiniger, A., et al. (2004) · Blood · doi:10.1182/blood-2004-03-0954 · Cited by 208
RetractedGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · cited 1×
“Gene expression microarray analysis has proved to be a powerful method for identifying novel subclasses of cancer and predicting clinical outcome or response to therapy (62,63).”
MethodJaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Cited by
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Self-citationEpigenetics and the biological definition of gene×environment interactions
Meaney, M. J. (2010) · Child Development · doi:10.1111/j.1467-8624.2009.01381.x · Cited by 1,239
Exploring the Genomes of Cancer Cells: Progress and Promise
Stratton, M. R. (2011) · Science · doi:10.1126/science.1204040 · Cited by 693
Is folic acid good for everyone?
Smith, A. D., Kim, Y.-I., & Refsum, H. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.517 · Cited by 612
Epigenetic Mechanisms and the Mismatch Concept of the Developmental Origins of Health and Disease
Godfrey, K. M., Lillycrop, K. A., Burdge, G. C., Gluckman, P. D., & Hanson, M. A. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e318045bedb · Cited by 595
Reactive Oxygen Species (ROS)––Induced genetic and epigenetic alterations in human carcinogenesis
Ziech, D., Franco, R., Pappa, A., & Panayiotidis, M. I. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.02.015 · Cited by 568
Epigenetics and the environmental regulation of the genome and its function
Zhang, T.-Y., & Meaney, M. J. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.60.110707.163625 · Cited by 565
A novel retinoblastoma therapy from genomic and epigenetic analyses
Zhang, J., Benavente, C. A., McEvoy, J., Flores-Otero, J., Ding, L., Chen, X., Ulyanov, A., Wu, G., Wilson, M., Wang, J., et al. (2012) · Nature · doi:10.1038/nature10733 · Cited by 516
Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics
Link, A., Balaguer, F., & Goel, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.036 · Cited by 497
Environmental chemical exposures and human epigenetics
Hou, L., Zhang, X., Wang, D., & Baccarelli, A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr154 · Cited by 483
Epigenetics and human disease: translating basic biology into clinical applications
Rodenhiser, D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050774 · Cited by 473
Dietary Polyphenols May Affect DNA Methylation
Fang, M., Chen, D., & Yang, C. S. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.1.223s · Cited by 462
Molecular Classification and Correlates in Colorectal Cancer
Ogino, S., & Goel, A. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070082 · Cited by 460
Metabolic Shifts in Immunity and Inflammation
Kominsky, D. J., Campbell, E. L., & Colgan, S. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903002 · Cited by 416
Ogino, S., Kawasaki, T., Brahmandam, M., Cantor, M., Kirkner, G. J., Spiegelman, D., Makrigiorgos, G. M., Weisenberger, D. J., Laird, P. W., Loda, M., et al. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050135 · Cited by 409
Self-citationFrigola, J., Song, J., Stirzaker, C., Hinshelwood, R. A., Peinado, M. A., & Clark, S. J. (2006) · Nature Genetics · doi:10.1038/ng1781 · Cited by 409
Ogino, S., Kawasaki, T., Kirkner, G. J., Kraft, P., Loda, M., & Fuchs, C. S. (2007) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.060170 · Cited by 369
Ogino, S., Cantor, M., Kawasaki, T., Brahmandam, M., Kirkner, G. J., Weisenberger, D. J., Campan, M., Laird, P. W., Loda, M., & Fuchs, C. S. (2006) · Gut · doi:10.1136/gut.2005.082933 · Cited by 359
Self-citationCollotta, M., Bertazzi, P. A., & Bollati, V. (2013) · Toxicology · doi:10.1016/j.tox.2013.01.017 · Cited by 305
Hanson, M., Godfrey, K. M., Lillycrop, K. A., Burdge, G. C., & Gluckman, P. D. (2011) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2010.12.008 · Cited by 299
Polycyclic Aromatic Hydrocarbons and Digestive Tract Cancers: A Perspective
Diggs, D. L., Huderson, A. C., Harris, K. L., Myers, J. N., Banks, L. D., Rekhadevi, P. V., Niaz, M. S., & Ramesh, A. (2011) · Journal of Environmental Science and Health, Part C · doi:10.1080/10590501.2011.629974 · Cited by 296
Tost, J. (2010) · Molecular Biotechnology · doi:10.1007/s12033-009-9216-2 · Cited by 296
Ogino, S., Kawasaki, T., Kirkner, G. J., Loda, M., & Fuchs, C. S. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.060082 · Cited by 294
Cancer Epigenetics: Modifications, Screening, and Therapy
Einav Nili, G.-Y., Saito, Y., Egger, G., & Jones, P. A. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061606.095816 · Cited by 270
Cancer Epigenetics: An Introduction
Kanwal, R., Gupta, K., & Gupta, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-1804-1_1 · Cited by 259
Hiraga, J., Tomita, A., Sugimoto, T., Shimada, K., Ito, M., Nakamura, S., Kiyoi, H., Kinoshita, T., & Naoe, T. (2009) · Blood · doi:10.1182/blood-2008-08-175208 · Cited by 257
Epigenetic targets of bioactive dietary components for cancer prevention and therapy
Meeran, S. M., Ahmed, A., & Tollefsbol, T. O. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0011-5 · Cited by 255
The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (Review)
Nguyen, H., & Duong, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8679 · Cited by 244
Epigenetics and the Biological Basis of Gene × Environment Interactions
Bagot, R. C., & Meaney, M. J. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.06.001 · Cited by 177
Bélanger, A.-S., Tojcic, J., Harvey, M., & Guillemette, C. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-9 · Cited by 86
Natural antisense transcripts regulate gene expression in an epigenetic manner
Su, W.-Y., Xiong, H., & Fang, J.-Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.147 · Cited by 71
“domains or entire chromosomes have an impact on gene expression, for instance, genomic imprinting [4,5].”
BackgroundPiazza, R., Magistroni, V., Mogavero, A., Andreoni, F., Ambrogio, C., Chiarle, R., Mologni, L., Bachmann, P. S., Lock, R. B., Collini, P., et al. (2013) · Neoplasia · doi:10.1593/neo.121784 · Cited by 51
Metadata
- Authors
- Laird, P. W.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-04-15
- Volume
- 14
- Issue
- suppl_1
- Pages
- R65-R76
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W4211231408
- Cited by
- 398
- References
- 158
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.